B
KLRS

Bailard’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bailard’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-952
Closed -$173K – 794
2022
Q3 		$173K Hold
952
– – 0.01% 613
2022
Q2 		$85K Buy
+952
New +$85K ﹤0.01% 665